ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Unicorn Pharmaceuticals Limited

Unicorn Pharmaceuticals Limited is an active company incorporated on 15 May 2023 with the registered office located in Stanmore, Greater London. Unicorn Pharmaceuticals Limited was registered 2 years 6 months ago.
Status
Active
Active since incorporation
Company No
14867894
Private limited company
Age
2 years 6 months
Incorporated 15 May 2023
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 28 February 2025 (8 months ago)
Next confirmation dated 28 February 2026
Due by 14 March 2026 (3 months remaining)
Last change occurred 8 months ago
Accounts
Submitted
For period 15 May31 Mar 2024 (10 months)
Accounts type is Total Exemption Full
Next accounts for period 31 March 2025
Due by 31 December 2025 (1 month remaining)
Address
Devonshire House
582 Honeypot Lane
Stanmore
Middlesex
HA7 1JS
England
Address changed on 10 Sep 2023 (2 years 2 months ago)
Previous address was 25 Park Street West Luton Bedfordshire LU1 3BE United Kingdom
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
3
Shareholders
1
Controllers (PSC)
2
Director • Indian • Lives in England • Born in Nov 1986
Director • Italian • Lives in Switzerland • Born in May 1964
Director • British • Lives in UK • Born in Oct 1957
Mr Hemant Kumar Verma
PSC • Indian • Lives in England • Born in Nov 1986
Mr Mallikarjuna Mullangi
PSC • Indian • Lives in UK • Born in Jan 1991
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
No mutual companies found
Financials
Net Assets, Total Assets & Total Liabilities (2024–2024)
Period Ended
31 Mar 2024
For period 1 May31 Mar 2024
Traded for 11 months
Cash in Bank
£584.73K
Turnover
Unreported
Employees
2
Total Assets
£622.48K
Total Liabilities
-£1.21M
Net Assets
-£584.85K
Debt Ratio (%)
194%
Latest Activity
Mr Massimo Berzigotti Appointed
7 Months Ago on 1 Apr 2025
Mallikarjuna Mullangi (PSC) Appointed
7 Months Ago on 28 Mar 2025
Mr Hemant Kumar Verma (PSC) Details Changed
7 Months Ago on 28 Mar 2025
Mr Richard Francis Howat Williams Appointed
7 Months Ago on 28 Mar 2025
Confirmation Submitted
8 Months Ago on 10 Mar 2025
Full Accounts Submitted
10 Months Ago on 23 Dec 2024
Confirmation Submitted
1 Year 2 Months Ago on 18 Sep 2024
Accounting Period Shortened
1 Year 2 Months Ago on 17 Sep 2024
Mr Hemant Kumar Verma (PSC) Details Changed
1 Year 9 Months Ago on 14 Feb 2024
Mr Hemant Kumar Verma Details Changed
1 Year 9 Months Ago on 14 Feb 2024
Get Credit Report
Discover Unicorn Pharmaceuticals Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Second filing for the appointment of Mr Massimo Berzigotti as a director
Submitted on 28 Apr 2025
Appointment of Mr Massimo Berzigotti as a director on 1 April 2025
Submitted on 11 Apr 2025
Appointment of Mr Richard Francis Howat Williams as a director on 28 March 2025
Submitted on 31 Mar 2025
Change of details for Mr Hemant Kumar Verma as a person with significant control on 28 March 2025
Submitted on 31 Mar 2025
Notification of Mallikarjuna Mullangi as a person with significant control on 28 March 2025
Submitted on 31 Mar 2025
Confirmation statement made on 28 February 2025 with updates
Submitted on 10 Mar 2025
Total exemption full accounts made up to 31 March 2024
Submitted on 23 Dec 2024
Statement of capital following an allotment of shares on 11 March 2024
Submitted on 23 Sep 2024
Confirmation statement made on 28 February 2024 with updates
Submitted on 18 Sep 2024
Previous accounting period shortened from 31 May 2024 to 31 March 2024
Submitted on 17 Sep 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year